Item 7.01. Regulation FD Disclosure
On
Item 9.01. Financial Statements and Exhibits.
(d)
Exhibits Item
99.1 Press release dated
© Edgar Online, source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.19 USD | -0.31% | +1.92% | +12.32% |
05-15 | Transcript : Aytu BioPharma, Inc., Q3 2024 Earnings Call, May 15, 2024 | |
05-15 | Earnings Flash (AYTU) AYTU BIOPHARMA Reports Q3 Revenue $18M, vs. Street Est of $17.4M | MT |
Item 7.01. Regulation FD Disclosure
On
Item 9.01. Financial Statements and Exhibits.
(d)
Exhibits Item
99.1 Press release dated
© Edgar Online, source
1st Jan change | Capi. | |
---|---|---|
+12.32% | 17.76M | |
+38.59% | 727B | |
-7.89% | 347B | |
+15.66% | 319B | |
+0.24% | 274B | |
+13.58% | 238B | |
+6.95% | 204B | |
-6.54% | 203B | |
+4.23% | 161B | |
-1.70% | 160B |